We’re tracking in-house compensation. Take the Law360 Survey
Click here
June 15, 2017
Guilfoile v. Shields, et al
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 26, 2023
The U.S. Department of Justice will put Teva Pharmaceuticals in grave danger by pursuing more than $10 billion at an impending False Claims Act trial, amplifying the need for immediate First Circuit review of a question on kickbacks that has cleaved other appellate courts, the drugmaker said Wednesday.
1 other articles on this case.
View all »
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Get instant access to the one-stop news source for business lawyers
Register Now!
Sign up now for free access to this content